Data / Form D filings / Hera Biotech, Inc.
Hera Biotech, Inc.: Form D filings
Hera Biotech, Inc., a biotechnology company in San Antonio, TX, filed 7 Form D notices with the SEC between 2020 and 2026. The latest, on September 23, 2026, reports $1.7 million sold of a $5 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4725 COLLEGE PARK, SUITE 200, San Antonio, TX, 78249
- Phone
- (210) 683-1069
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1831293
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Amendment | $5,000,000 | $1,736,823 | $3,263,177 | 26 | Apr 11, 2025 | sec.gov |
| Sep 23, 2025 | New notice | $5,000,000 | $796,328 | $4,203,672 | 8 | Apr 11, 2025 | sec.gov |
| Aug 12, 2024 | New notice | $6,000,000 | $0 | $6,000,000 | 0 | Aug 2, 2024 | sec.gov |
| May 31, 2023 | New notice | $1,000,000 | $260,000 | $740,000 | 4 | May 18, 2023 | sec.gov |
| Feb 15, 2022 | Amendment | $2,000,000 | $853,500 | $1,146,500 | 19 | Nov 3, 2020 | sec.gov |
| Jan 28, 2022 | Amendment | $1,500,000 | $803,500 | $696,500 | 18 | Nov 3, 2020 | sec.gov |
| Nov 10, 2020 | New notice | $250,000 | $95,000 | $155,000 | 5 | Nov 3, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Somer Baburek | Executive Officer, Director | |
| Paul Castella | Director | |
| Wendy Smith | Director | |
| Neal Walsdorf, Jr. | Director | |
| Teo Tijerina | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
- BioGene Therapeutics Inc. $3 million · Aug 7, 2026
Every Form D from the week of Sep 21, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Hera Biotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.